Abstract
This pilot study was aimed to value the feasibility and safety of Senhance Robotic Platform for hysterectomy in obese patients. Ten obese patients (30 < BMI < 40) underwent elective Senhance total extrafascial hysterectomy with bilateral salpingo-oophorectomy at the Division of Gynecologic Oncology of “Policlinico A. Gemelli” Foundation, Rome, Italy. Perioperative and postoperative outcomes data were recorded. The median age was 60 years (range 51–75) and the median BMI was 33.3 kg/m2 (range 30.4–38.3). The median uterine weight was 112.5 g (range 77–225). Indication to total hysterectomy was early-stage (FIGO Stage IA) endometrial cancer in 100% of patients. The median operative time (OT) was 110 min (70–200). The median docking time was 10.5 min (5–25). The median estimated blood loss was 100 mL (50–200). No conversions to laparotomy were recorded. No intra- and 30-day postoperative complications were registered. The median ileus was 17 h (12–36) and the median time to discharge was 2 days (1–4). The median VAS scores registered at 2, 4, 12, and 24 h were, respectively, 2 (1–3), 2 (1–3), 4 (1–8), and 3 (1–5). Our study results suggest that Senhance platform could be safe for hysterectomy even in obese patients. More clinical data are needed to determine whether this approach would offer any additional benefits in a new middle line between standard laparoscopy and robotics.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ogden CL, Carroll MD, Kit BK, Flegal KM (2014) Prevalence of childhood and adult obesity in the US, 2011–2012. JAMA 311(8):806–814
Corrado G, Chiantera V, Fanfani F, Cutillo G, Lucidi A, Mancini E, Pedone Anchora L, Scambia G, Vizza E (2016) Robotic hysterectomy in severely obese patients with endometrial cancer: a multicenter study. J Minim Invasive Gynecol 23(1):94–100
Obermair A, Manolitsas TP, Leung Y et al (2005) Total laparoscopic hysterectomy versus total abdominal hysterectomy for obese women with endometrial cancer. Int J Gynecol Cancer 15:319–324
Rabishong B, Larrain D, Canis M et al (2011) Long-term follow-up after laparoscopic management of endometrial cancer in the obese: a 15-year cohort study. J Minim Invasive Gynecol 18:589–596
Almeida OD Jr (2013) Robotic hysterectomy strategies in the morbidly obese patient. JSLS 17:418–422
Peiretti M, Zanagnolo V, Bocciolone L et al (2009) Robotic surgery: changing the surgical approach for endometrial cancer in a referral cancer center. J Minim Invasive Gynecol 16:427–431
Lowe MP, Johnson PR, Kamelle SA et al (2009) A multi institutional experience with robotic assisted hysterectomy with staging for endometrial cancer. Obstet Gynecol 114:236–243
Fanfani F, Monterossi G, Fagotti A, Rossitto C, Gueli Alletti S, Costantini B, Gallotta V, Selvaggi L, Restaino S, Scambia G (2016) The new robotic TELELAP ALF-X in gynecological surgery: single-center experience. Surg Endosc 30(1):215–221
Fanfani F, Restaino S, Gueli Alletti S, Fagotti A, Monterossi G, Rossitto C, Costantini B, Scambia G (2015) TELELAP ALF-X Robotic-assisted Laparoscopic Hysterectomy: Feasibility and Perioperative Outcomes. J Minim Invasive Gynecol 22(6):1011–1017
Gueli Alletti S, Rossitto C, Fanfani F, Fagotti A, Costantini B, Gidaro S, Monterossi G, Selvaggi L, Scambia G (2015) Telelap Alf-X-assisted laparoscopy for ovarian cyst enucleation: report of the first 10 cases. J Minim Invasive Gynecol 22(6):1079–1083
Gueli Alletti S, Rossitto C, Cianci S, Restaino S, Costantini B, Fanfani F et al (2015) TELELAP ALF-X versus standard laparoscopy for the treatment of early-stage endometrial cancer: a single-institution retrospective cohort study. J Minim Invasive Gynecol. doi:10.1016/j.jmig.2015.11.006 (Epub ahead of print)
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
Querleu S, Morrow CP (2008) Classification of radical hysterectomy. Lancet Oncol 9(3):297–303
Gueli Alletti S, Rossitto C, Cianci S, Scambia G (2016) Telelap ALF-X hysterectomy for early stage endometrial cancer: new frontier of robotic gynecological surgery. Gynecol Oncol 140(3):575–576. doi:10.1016/j.ygyno.2016.01.018 (Epub 2016 Jan 21)
Fanfani F, Fagotti A, Rossitto C et al (2012) Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes. Surg Endosc 26:3592–3596
Liu H, Lu D, Shi G, Song H, Wang L (2014) WITHDRAWN: robotic surgery for benign gynaecological disease. Cochrane Database Syst Rev (12):CD008978
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no funding sources to disclose for this work. Dr Gidaro and Dr Gueli Alletti are Consultants for Transenterix. Dr Rossitto, Dr Cianci, Dr Perrone, Dr Monterossi, Dr Pizzacalla, Dr Vizzielli, and Dr Scambia have no conflicts of interest to disclose.
Ethical approval
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
Rights and permissions
About this article
Cite this article
Gueli Alletti, S., Rossitto, C., Cianci, S. et al. The Senhance™ surgical robotic system (“Senhance”) for total hysterectomy in obese patients: a pilot study. J Robotic Surg 12, 229–234 (2018). https://doi.org/10.1007/s11701-017-0718-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11701-017-0718-9